Savara announces new employment inducement grant

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. on december 11, 2023, the compensation committee of savara's board of directors granted the inducement awards to a new employee who recently joined the company. the inducement awards consist of options to purchase 110,000 shares of the company's common stock and restricted stock units (rsus).
SVRA Ratings Summary
SVRA Quant Ranking